Methylated Genes in Blood as Biomarkers for Advanced Lung Cancer

CompletedOBSERVATIONAL
Enrollment

281

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

November 30, 2010

Study Completion Date

November 30, 2010

Conditions
Lung Cancer
Interventions
OTHER

Blood and Tissue studies

Blood will be collected from participating patients at baseline, as close as possible to the date of their baseline radiologic assessment. Three follow-up blood collections will be drawn, each within 7-10 days of each follow-up radiologic evaluation.

Trial Locations (1)

10065

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

University of Southern California

OTHER

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00579462 - Methylated Genes in Blood as Biomarkers for Advanced Lung Cancer | Biotech Hunter | Biotech Hunter